Details

Last Funding Type

Series C

Last Funding Money Raised

$50.37M

Industries

Biotechnology,Genetics,Health Care,Medical,Therapeutics

Founded date

Jan 1, 1999

Number Of Employee

51 - 100

Operating Status

Close

Anesiva, Inc., a biopharmaceutical company, engages in the development and commercialization of novel therapeutic treatments for pain management worldwide. Its lead product candidate includes Adlea, which completed multiple Phase II and Phase III trials for post-surgical, musculoskeletal, and neuropathic pain. The company was formerly known as AlgoRx Pharmaceuticals, Inc., it changed its name to Anesiva, Inc. in 2006. Anesiva, Inc. was founded in 1999 and is headquartered in South San Francisco, California. On January 15, 2010, Anesiva, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Northern District of California.

On June 10, 2014 filed for Chapter 7 bankruptcy.